Gilead Sciences Inc
NASDAQ: GILD
$83.94
+$0.04 (+0.0%)
Closing Price on September 20, 2024
GILD Articles
The January 29 short interest data have been compared with the previous report, and short interest was mixed in most of the selected biotech stocks.
Published:
Last Updated:
After Gilead Sciences reported fourth-quarter financial results on Tuesday, analysts weighed in on this biotech giant and in what direction it might go next.
Published:
Last Updated:
Gilead Sciences reported better-than-expected fourth-quarter financial results after the markets closed on Tuesday.
Published:
Last Updated:
February 2, 2016: Here are five stocks trading with heavy volume among 209 equities making new 52-week lows today. Tesla Motors Inc. (NASDAQ: TSLA) dropped about 8.5% on Tuesday, posting a new...
Published:
Last Updated:
Gilead Sciences is set to release its fourth-quarter earnings report after the markets close on Tuesday.
Published:
Last Updated:
February 1, 2016: Here are four stocks trading with heavy volume among 96 equities making new 52-week lows today. Gilead Sciences Inc. (NASDAQ: GILD) dropped about 0.9% on Monday to post a new...
Published:
Last Updated:
A recent Jefferies research note indicates that the multiples for the four largest biotechs have dipped below that of the S&P for the first time since early in 2011, despite displaying higher...
Published:
Last Updated:
January 29, 2016: Here are four stocks trading with heavy volume among 119 equities making new 52-week lows today. Gilead Sciences Inc. (NASDAQ: GILD) dropped about 5.8% on Friday to post a new...
Published:
Last Updated:
Short interest increased in most of these selected biotech stocks for the most recent settlement date.
Published:
Last Updated:
Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. It initiated several top biotech stocks with an Outperform rating.
Published:
Last Updated:
Wednesday's top analyst calls include AMD, Amazon.com, Celgene, Comerica, Fortinet, Gilead Sciences, Lennar, Netflix, Voya and Wayfair.
Published:
Last Updated:
Merrill Lynch sees some stabilization in the hepatitis C market in 2016 that might allow Gilead Sciences to stay above water this year.
Published:
Last Updated:
Friday's top analyst calls include Best Buy, 3D Systems, Electronic Arts, Gilead Sciences, Nokia, Shire and United Rentals.
Published:
Last Updated:
The short interest data are out for the December 31 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
Published:
Last Updated:
This is going to be a big year in biotech, with a host of drugs set to undergo FDA scrutiny. These four companies with promising candidates all have dates with the agency this year.
Published:
Last Updated: